Cure Pharmaceutical Holding Stock Forecast

Hold candidate since Aug 07, 2026

The CURE Pharmaceutical Holding Corp. stock price gained 2.30% on the last trading day (Friday, 7th Aug 2026), rising from $3.04 to $3.11. During the last trading day the stock fluctuated 3.61% from a day low at $3.05 to a day high of $3.16. The price has risen in 6 of the last 10 days but is still down by -4.01% for this period. Volume fell on the last day by -82 thousand shares and in total, 25 thousand shares were bought and sold for approximately $78.69 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -10.52% during the next 3 months and, with a 90% probability hold a price between $2.16 and $3.60 at the end of this 3-month period.

CURR Signals & Forecast

The CURE Pharmaceutical Holding Corp. stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $3.22. On a fall, the stock will find some support from the long-term average at approximately $3.07. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. A buy signal was issued from a pivot bottom point on Thursday, July 02, 2026, and so far it has risen 19.62%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may not be. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for CURE Pharmaceutical Holding Corp. stock

On the downside, the stock finds support just below today's level from accumulated volume at $2.95 and $2.69. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, CURE Pharmaceutical Holding Corp. finds support just below today's level at $2.95. If this is broken, then the next support from accumulated volume will be at $2.69 and $2.68.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.110 between high and low, or 3.61%. For the last week the stock has had daily average volatility of 6.87%.

Our recommended stop-loss: $2.99 (-3.72%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 25 days ago.)

Trading Expectations (CURR) For The Upcoming Trading Day Of Monday 10th

For the upcoming trading day on Monday, 10th we expect CURE Pharmaceutical Holding Corp. to open at $3.11, and during the day (based on 14 day Average True Range), to move between $2.99 and $3.23, which gives a possible trading interval of +/-$0.246 (+/-8.25%) up or down from last closing price. If CURE Pharmaceutical Holding Corp. takes out the full calculated possible swing range there will be an estimated 8.25% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $2.95 (5.14%) than the resistance at $3.27 (5.14%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is CURE Pharmaceutical Holding Corp. stock A Buy?

CURE Pharmaceutical Holding Corp. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold candidate.

Current score: 0.326 Hold/Accumulate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on August 10, 2026 - $3.11 ( 0.107%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk